scholarly article | Q13442814 |
P356 | DOI | 10.1002/PATH.941 |
P698 | PubMed publication ID | 11592098 |
P2093 | author name string | Poulsom R | |
Hart IR | |||
Gillett CE | |||
Hanby AM | |||
Assmann V | |||
Ryder K | |||
P433 | issue | 2 | |
P304 | page(s) | 191-196 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells | |
P478 | volume | 195 |
Q35584153 | A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy |
Q37466336 | Cancer therapy using tumor-associated antigens to reduce side effects |
Q46705812 | Collagens, stromal cell-derived factor-1alpha and basic fibroblast growth factor increase cancer cell invasiveness in a hyaluronan hydrogel |
Q38353668 | Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer |
Q37802570 | Definition of a Target for Immunotherapy and Results of the First Peptide Vaccination Study in Chronic Lymphocytic Leukemia |
Q39859848 | Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a 3-D system |
Q28200947 | Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis |
Q37731962 | Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck |
Q46528804 | Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. |
Q54517252 | Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). |
Q47105832 | Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities |
Q27006607 | Hyaluronan, Inflammation, and Breast Cancer Progression |
Q41770223 | Increased RHAMM expression relates to ovarian cancer progression. |
Q35693859 | Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis |
Q34081324 | Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer |
Q28304661 | Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility |
Q63444335 | Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer |
Q33854876 | Prognostic impact of CD168 expression in gastric cancer |
Q38823693 | Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma |
Q35289524 | Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis |
Q38199975 | Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers |
Q38927595 | Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion |
Q28539229 | Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer |
Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
Q53429971 | The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia. |
Q27025313 | The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression |
Q47989507 | hmmr mediates anterior neural tube closure and morphogenesis in the frog Xenopus |
Search more.